Financial results - TRIALURI CLINICE ONCOLOGIE SRL

Financial Summary - Trialuri Clinice Oncologie Srl
Unique identification code: 37014129
Registration number: J16/185/2017
Nace: 6820
Sales - Ron
3.201.845
Net Profit - Ron
1.259.267
Employee
14
The most important financial indicators for the company Trialuri Clinice Oncologie Srl - Unique Identification Number 37014129: sales in 2023 was 3.201.845 euro, registering a net profit of 1.259.267 euro and having an average number of 14 employees. Firma isi desfasoara activitatea in domeniul Inchirierea si subinchirierea bunurilor imobiliare proprii having the NACE code 6820.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Trialuri Clinice Oncologie Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 301.769 940.177 1.327.812 1.172.647 2.258.637 3.290.344 3.201.845
Total Income - EUR - - - 301.848 940.372 1.328.430 1.174.341 2.260.970 3.293.483 3.637.821
Total Expenses - EUR - - - 27.036 107.918 299.932 604.785 1.141.016 1.419.012 2.171.845
Gross Profit/Loss - EUR - - - 274.812 832.454 1.028.498 569.557 1.119.954 1.874.471 1.465.976
Net Profit/Loss - EUR - - - 267.632 823.052 956.746 478.613 966.110 1.824.795 1.259.267
Employees - - - 1 8 13 11 14 14 14
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -2.4%, from 3.290.344 euro in the year 2022, to 3.201.845 euro in 2023. The Net Profit decreased by -559.995 euro, from 1.824.795 euro in 2022, to 1.259.267 in the last year.

Check the financial reports for the company - Trialuri Clinice Oncologie Srl

Rating financiar

Financial Rating -
Trialuri Clinice Oncologie Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Trialuri Clinice Oncologie Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Trialuri Clinice Oncologie Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Trialuri Clinice Oncologie Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Trialuri Clinice Oncologie Srl - CUI 37014129

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 1.424.129 2.377.712 8.573.738 12.399.262 12.618.971 14.298.091 14.783.652
Current Assets - - - 167.431 339.482 2.617.163 525.961 336.714 735.024 317.036
Inventories - - - 0 0 5.160 31.841 0 0 0
Receivables - - - 2.751 234.408 2.445.165 332.787 150.079 215.953 151.716
Cash - - - 164.679 105.074 166.838 161.333 186.635 519.071 165.320
Shareholders Funds - - - 267.676 823.104 1.763.909 2.209.083 3.126.204 2.060.998 3.314.015
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 1.323.884 1.894.090 9.426.992 10.718.140 9.832.619 12.981.024 11.796.629
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "6820 - 6820"
CAEN Financial Year 6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 317.036 euro in 2023 which includes Inventories of 0 euro, Receivables of 151.716 euro and cash availability of 165.320 euro.
The company's Equity was valued at 3.314.015 euro, while total Liabilities amounted to 11.796.629 euro. Equity increased by 1.259.267 euro, from 2.060.998 euro in 2022, to 3.314.015 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Trialuri Clinice Oncologie Srl

Comments - Trialuri Clinice Oncologie Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.